Direct prospective comparison of circulating tumor DNA and tissue biopsy sequencing shows the superiority of liquid biopsies for capturing clinically relevant alterations mediating resistance to targeted therapies in cancer patients.
- Aparna R. Parikh
- Ignaty Leshchiner
- Ryan B. Corcoran